With experienced researchers and sites, investment in research infrastructure by local and overseas organizations as well as engaged stakeholders, Africa should be a research destination for pharma, biotech, government and non-governmental organizations alike.
The Sooner, the Better: Planning for FDA Pre-IND Review of COVID-19 Studies
One strategy to reaching endemic status for COVID-19 globally is equitable access to vaccines and therapies. Studies such as the one we’re supporting in Ghana will help with this.
Although the diversity of Africa is often cited, the full extent is still not well understood. As we learn more, the true potential of the continent for clinical research to address ongoing public health issues becomes apparent.